Serum calcium in thyroid disease. 2001

S Begic-Karup, and B Wagner, and W Raber, and B Schneider, and A Hamwi, and W Waldhäusl, and H Vierhapper
Division of Endocrinology and Metabolism, Department of Internal Medicine III.

Thyroid hormones are believed to influence calcium metabolism. In the present prospective study we investigated the influence of various thryroid diseases on serum calcium levels. In addition to screening for thyroid diseases we measured serum calcium concentrations (S-Ca) in individuals who came to our outpatient service for thyroid diseases from 1992 to 1998. 13,387 persons, among them 9017 patients with thyroid diseases and 4370 persons without thyroid dysfunction, were studied. S-Ca was found to be higher in patients with hyperthyroidism (2.36 +/- 0.11 mmol/L n = 1201, p < 0.05) than in those with subclinical hyperthyroidism (2.33 +/- 0.11 mmol/L, n = 494), with euthyroid goiter (2.32 +/- 0.10 mmol/l, n = 5599), with hypothyroidism (2.31 +/- 0.11 mmol/L, 344), with subclinical hypothyroidism (2.32 +/- 0.10 mmol/L, n = 1290) and in healthy persons (2.31 +/- 0.11 mmol/L, n = 4370). 173/13,387 persons had serum calcium levels < 2.1 mmol/L, among them 31 patients with hypoparathyroidism after strumectomy (31/592) and 2 patients with primary hypoparathyroidism. 106/13,387 persons showed a S-Ca of > 2.6 mmol/L, which in 30 cases was due to primary hyperparathyroidism. Of 55 persons with S-Ca of > 2.6 mmol/L and without any other reason for hypercalcaemia, 31 were found to be in a hyperthyroid state. In conclusion, a clinically not relevant influence on S-Ca was demonstrated in patients with hyperthyroidism as compared with other thyroid diseases and individuals with no thyroid diseases. Measurement of S-Ca in every patient being referred to a thyroid outpatient department is recommended because of the frequent occurrence of postoperative hypoparathyroidism and primary hyperparathyroidism in this setting.

UI MeSH Term Description Entries
D006961 Hyperparathyroidism A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
D006962 Hyperparathyroidism, Secondary Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY. Secondary Hyperparathyroidism,Hyperparathyroidisms, Secondary,Secondary Hyperparathyroidisms
D006980 Hyperthyroidism Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE. Hyperthyroid,Primary Hyperthyroidism,Hyperthyroidism, Primary,Hyperthyroids
D006996 Hypocalcemia Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed) Hypocalcemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011159 Population Surveillance Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy. Surveillance, Population
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D005260 Female Females

Related Publications

S Begic-Karup, and B Wagner, and W Raber, and B Schneider, and A Hamwi, and W Waldhäusl, and H Vierhapper
June 1958, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
S Begic-Karup, and B Wagner, and W Raber, and B Schneider, and A Hamwi, and W Waldhäusl, and H Vierhapper
January 1988, Journal of endocrinological investigation,
S Begic-Karup, and B Wagner, and W Raber, and B Schneider, and A Hamwi, and W Waldhäusl, and H Vierhapper
November 1942, The Journal of clinical investigation,
S Begic-Karup, and B Wagner, and W Raber, and B Schneider, and A Hamwi, and W Waldhäusl, and H Vierhapper
June 1980, Acta endocrinologica,
S Begic-Karup, and B Wagner, and W Raber, and B Schneider, and A Hamwi, and W Waldhäusl, and H Vierhapper
October 1987, British journal of pharmacology,
S Begic-Karup, and B Wagner, and W Raber, and B Schneider, and A Hamwi, and W Waldhäusl, and H Vierhapper
May 1971, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
S Begic-Karup, and B Wagner, and W Raber, and B Schneider, and A Hamwi, and W Waldhäusl, and H Vierhapper
February 2007, International journal of surgery (London, England),
S Begic-Karup, and B Wagner, and W Raber, and B Schneider, and A Hamwi, and W Waldhäusl, and H Vierhapper
October 1971, Journal of dairy science,
S Begic-Karup, and B Wagner, and W Raber, and B Schneider, and A Hamwi, and W Waldhäusl, and H Vierhapper
September 1972, Clinical and experimental immunology,
S Begic-Karup, and B Wagner, and W Raber, and B Schneider, and A Hamwi, and W Waldhäusl, and H Vierhapper
January 1963, Metabolism: clinical and experimental,
Copied contents to your clipboard!